BioTime doses first patient in OpRegen clinical study

Image: The FDA 510K approved Orbit SDS avoids the need for a vitrectomy and perforation of the retina. Photo: Courtesy of skeeze from Pixabay.



Related Article
Recommended Whitepaper

View More